3-amino-1,2,4-triazine has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bassani, D; Carbone, D; Cascioferro, S; Cirrincione, G; Dall'Acqua, S; De Franco, M; Diana, P; Gandin, V; Moro, S; Parrino, B; Pavan, M; Pecoraro, C | 1 |
Bassani, D; Carbone, D; Cascioferro, S; Cirrincione, G; Dall'Acqua, S; De Franco, M; Diana, P; Gandin, V; Moro, S; Parrino, B; Pavan, M; Pecoraro, C; Sut, S | 1 |
2 other study(ies) available for 3-amino-1,2,4-triazine and Adenocarcinoma
Article | Year |
---|---|
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma.
Topics: Adenocarcinoma; Humans; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Small Molecule Libraries | 2023 |
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Triazines | 2023 |